We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$40.9B
AUM Growth
+$673M
(+1.7%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
3.14%
Top 10 Holdings %
Top 10 Hldgs %
11.68%
Holding
2,544
New
250
Increased
807
Reduced
1,116
Closed
346
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$292M |
| 2 |
Cisco
CSCO
|
+$289M |
| 3 |
Microsoft
MSFT
|
+$289M |
| 4 |
Lowe's Companies
LOW
|
+$262M |
| 5 |
Visa
V
|
+$252M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$317M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$240M |
| 3 |
Dollar Tree
DLTR
|
+$163M |
| 4 |
Wayfair
W
|
+$150M |
| 5 |
Ulta Beauty
ULTA
|
+$143M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.69% |
| 2 | Consumer Discretionary | 15.78% |
| 3 | Healthcare | 14.42% |
| 4 | Industrials | 10.75% |
| 5 | Financials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Lexicon Pharmaceuticals
LXRX
$973M
| $191K | ﹤0.01% |
63,616
+36,600
| +135% | +$113K |
|
|
VOXX
2052
DELISTED
VOXX International Corporation Class A
VOXX
| $191K | ﹤0.01% |
40,534
| – | – |
|
|
MYND
2053
Mynd.ai
MYND
$18.1M
| $188K | ﹤0.01% |
2,938
-1,880
| -39% | -$120K |
|
2054
Corcept Therapeutics
CORT
$9.8B
| $187K | ﹤0.01% |
13,200
+2,200
| +20% | +$27K |
|
|
ARC
2055
DELISTED
ARC Document Solutions, Inc.
ARC
| $187K | ﹤0.01% |
137,810
-6,000
| -4% | -$9.67K |
|
|
FENG
2056
Phoenix New Media
FENG
$17.4M
| $186K | ﹤0.01% |
12,084
-500
| -4% | -$8.87K |
|
2057
Lineage Cell Therapeutics
LCTX
$257M
| $184K | ﹤0.01% |
187,966
+17,977
| +11% | +$18.6K |
|
2058
Construction Partners
ROAD
$5.86B
| $184K | ﹤0.01% |
11,800
-21,500
| -65% | -$321K |
|
|
IMMU
2059
DELISTED
Immunomedics Inc
IMMU
| $184K | ﹤0.01% |
13,900
+1,500
| +12% | +$22.1K |
|
2060
Sportsman's Warehouse
SPWH
$45.3M
| $182K | ﹤0.01% |
35,100
+8,400
| +31% | +$36.2K |
|
2061
Nabors Industries
NBR
$1.16B
| $180K | ﹤0.01% |
+1,921
| New | +$216K |
|
2062
Pearson
PSO
$10.1B
| $178K | ﹤0.01% |
19,700
-21,400
| -52% | -$222K |
|
|
PSTL
2063
Postal Realty Trust
PSTL
$722M
| $177K | ﹤0.01% |
+11,200
| New | +$170K |
|
|
EIGR
2064
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $177K | ﹤0.01% |
575
-280
| -33% | -$91K |
|
|
HMTV
2065
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $177K | ﹤0.01% |
14,500
+2,900
| +25% | +$36K |
|
2066
Larimar Therapeutics
LRMR
$398M
| $176K | ﹤0.01% |
19,883
+4,800
| +32% | +$52.6K |
|
2067
Oil States International
OIS
$515M
| $176K | ﹤0.01% |
13,255
-13,600
| -51% | -$196K |
|
2068
Vaalco Energy
EGY
$554M
| $175K | ﹤0.01% |
86,306
+27,900
| +48% | +$49.2K |
|
|
NVTR
2069
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $173K | ﹤0.01% |
127,200
+36,100
| +40% | +$70.8K |
|
2070
Mercer International
MERC
$44.4M
| $172K | ﹤0.01% |
13,718
-44,741
| -77% | -$565K |
|
2071
ICL Group
ICL
$6.66B
| $168K | ﹤0.01% |
33,600
-1,600
| -5% | -$7.98K |
|
2072
Aclaris Therapeutics
ACRS
$736M
| $167K | ﹤0.01% |
+155,000
| New | +$220K |
|
2073
TriplePoint Venture Growth BDC
TPVG
$181M
| $166K | ﹤0.01% |
10,100
-123,100
| -92% | -$1.93M |
|
|
AHG
2074
Akso Health Group
AHG
$1.21B
| $163K | ﹤0.01% |
35,442
+3,600
| +11% | +$22.6K |
|
2075
Transportadora de Gas del Sur
TGS
$4.56B
| $161K | ﹤0.01% |
+19,731
| New | +$218K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, Two Sigma Advisers held 2,544 positions worth $40.9B, up 1.7% from $40.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Two Sigma Advisers deployed $1.28B of net new capital in Q3 2019, opening 250 new positions and adding to 807 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 500,527 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $317M trimmed.
- Two Sigma Advisers's largest Q3 2019 buy was State Street SPDR S&P 500 ETF Trust: 500,527 shares worth $149M.
- Two Sigma Advisers added most to Alphabet (Google) Class A in Q3 2019, an estimated $292M increase.
- Two Sigma Advisers's biggest Q3 2019 reduction was Amgen, cutting an estimated $317M.
- Two Sigma Advisers fully exited Red Hat Inc in Q3 2019, selling an estimated $137M.
- Two Sigma Advisers's ten largest holdings make up 12% of its $40.9B portfolio in Q3 2019.
- Two Sigma Advisers opened 250 new positions and closed 346 in Q3 2019.
- Two Sigma Advisers's portfolio value rose 1.7% quarter-over-quarter to $40.9B.
Based on Two Sigma Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.